Imipramine Hydrochloride is a tricyclic antidepressant primarily used to treat major depressive disorder and enuresis in children.
Imipramine Hydrochloride is a tricyclic antidepressant (TCA) that is primarily used in the treatment of major depressive disorder and enuresis (bedwetting) in children. It functions by inhibiting the reuptake of norepinephrine and serotonin, two neurotransmitters that play a crucial role in mood regulation and emotional stability. This mechanism enhances the synaptic concentration of these neurotransmitters, thereby improving mood and emotional response.
In addition to its antidepressant properties, Imipramine Hydrochloride exhibits anticholinergic and sedative effects, which can be beneficial in managing anxiety and insomnia associated with depression. However, these effects also necessitate careful monitoring for potential side effects such as dry mouth, constipation, and urinary retention. Prescribers should be aware of the potential for Imipramine to interact with other medications, particularly monoamine oxidase inhibitors (MAOIs) and selective serotonin reuptake inhibitors (SSRIs), which can lead to serious adverse reactions.
Imipramine Hydrochloride is metabolized in the liver, primarily by the cytochrome P450 enzyme system, and is excreted in the urine. This pharmacokinetic profile underscores the importance of dose adjustments in patients with hepatic or renal impairment to avoid toxicity. The therapeutic efficacy and safety of Imipramine can be influenced by genetic polymorphisms affecting drug metabolism, making pharmacogenetic testing a consideration in personalized treatment plans.
For healthcare providers, understanding the comprehensive profile of Imipramine Hydrochloride is essential for optimizing treatment outcomes and minimizing risks. Its use in compounded formulations allows for tailored dosing and delivery methods, enhancing patient adherence and therapeutic success. As with all TCAs, a gradual titration of dosage is recommended to mitigate the risk of adverse effects and to monitor patient response effectively.
Each of these is compounded to order at our Warwick, Rhode Island pharmacy and requires a prescription.
We do not have a patient page for this ingredient yet. That does not mean we cannot make it. Bayview compounds this ingredient to a prescriber's order, and our full compounding formulary lists every preparation we make. Viewing the formulary requires a prescriber account.
Prescriber sign inA sample of preparations from our formulary. Strengths and dose forms are customised to the prescription.
Other salt forms of this molecule, and ingredients commonly compounded alongside it.
This page describes an active pharmaceutical ingredient, not a finished drug product. Bayview Pharmacy compounds preparations containing it only on a prescriber's order for an individual patient.
Compounded preparations are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. Nothing on this page is a claim that any preparation is effective for any condition.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Our pharmacists work with prescribers to build preparations around a patient's dose, form and tolerances. Ask us what is possible with this ingredient.